Follow
Danielle Vuichard Gysin
Danielle Vuichard Gysin
Leitende Ärztin Infektiologie & Spitalhygiene, Spital Thurgau AG; Head of Research & Development
Verified email at stgag.ch - Homepage
Title
Cited by
Cited by
Year
Risk of SARS-CoV-2 transmission by aerosols, the rational use of masks, and protection of healthcare workers from COVID-19
R Sommerstein, CA Fux, D Vuichard-Gysin, M Abbas, J Marschall, ...
Antimicrobial Resistance & Infection Control 9 (1), 1-8, 2020
3122020
Effect of vitamin D3 supplementation on respiratory tract infections in healthy individuals: a systematic review and meta-analysis of randomized controlled trials
DV Gysin, D Dao, CM Gysin, L Lytvyn, M Loeb
PLoS One 11 (9), e0162996, 2016
1102016
The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem …
R Thoma, M Seneghini, SN Seiffert, D Vuichard Gysin, G Scanferla, ...
Antimicrobial Resistance & Infection Control 11 (1), 1-11, 2022
792022
The clinical effectiveness of pneumococcal conjugate vaccines: a systematic review and meta-analysis of randomized controlled trials
H Ewald, M Briel, D Vuichard, V Kreutle, A Zhydkov, V Gloy
Deutsches Ärzteblatt International 113 (9), 139, 2016
582016
Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study
N Boillat-Blanco, KEA Darling, F Schoni-Affolter, D Vuichard, ...
Antivir Ther 20 (2), 165-75, 2015
572015
Hypoxia aggravates lipopolysaccharide‐induced lung injury
D Vuichard, MT Ganter, RC Schimmer, D Suter, C Booy, L Reyes, T Pasch, ...
Clinical & Experimental Immunology 141 (2), 248-260, 2005
462005
Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among Hospital Workers–a multicentre cross-sectional study
CR Kahlert, R Persi, S Güsewell, T Egger, OB Leal-Neto, J Sumer, D Flury, ...
Clinical Microbiology and Infection, 2021
452021
Cohort profile: SARS-CoV-2/COVID-19 hospitalised patients in Switzerland
A Thiabaud, ACM Iten, C Balmelli, L Senn, N Troillet, A Widmer, D Flury, ...
Swiss medical weekly 151, w20475, 2021
332021
Comparative effectiveness of tenofovir in treatment-naive HIV-infected patients: systematic review and meta-analysis
LG Hemkens, H Ewald, M Santini-Oliveira, JE Bühler, D Vuichard, ...
HIV clinical trials 16 (5), 178-189, 2015
302015
Impact of respirator versus surgical masks on SARS-CoV-2 acquisition in healthcare workers: a prospective multicentre cohort
S Haller, S Güsewell, T Egger, G Scanferla, R Thoma, OB Leal-Neto, ...
Antimicrobial Resistance & Infection Control 11 (1), 1-11, 2022
242022
Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19—a prospective multicenter cohort study
P Kohler, S Güsewell, M Seneghini, T Egger, O Leal, A Brucher, ...
BMC medicine 19 (1), 1-10, 2021
242021
Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study.
FM Maximiano Alves de Sousa, M Roelens, B Friker, A Thiabaud, A Iten, ...
Swiss medical weekly 151 (w20547), 2021
212021
Development and validation of clinical prediction models to distinguish influenza from other viruses causing acute respiratory infections in children and adults
D Vuichard-Gysin, D Mertz, E Pullenayegum, P Singh, M Smieja, M Loeb
PloS one 14 (2), e0212050, 2019
212019
Variability in contact precautions to control the nosocomial spread of multi-drug resistant organisms in the endemic setting: a multinational cross-sectional survey
DV Gysin, B Cookson, H Saenz, M Dettenkofer, AF Widmer
Antimicrobial Resistance & Infection Control 7 (1), 81, 2018
202018
Increasing proportion of vancomycin resistance among enterococcal bacteraemias in Switzerland: a 6-year nation-wide surveillance, 2013 to 2018
V Piezzi, M Gasser, A Atkinson, A Kronenberg, D Vuichard-Gysin, ...
Eurosurveillance 25 (35), 1900575, 2020
192020
Impact of the COVID-19 Pandemic on Inpatient Antibiotic Consumption in Switzerland
O Friedli, M Gasser, A Cusini, R Fulchini, D Vuichard-Gysin, ...
Antibiotics 11 (6), 792, 2022
152022
Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection—Results …
C Strahm, M Seneghini, S Güsewell, T Egger, O Leal-Neto, A Brucher, ...
Clinical Infectious Diseases, 2022
152022
Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19
GM Fröhlich, MEA De Kraker, M Abbas, O Keiser, A Thiabaud, M Roelens, ...
Eurosurveillance 27 (1), 2001848, 2022
142022
Aktualisierte Empfehlungen zur perioperativen Antibiotikaprophylaxe in der Schweiz, 2015
L Senn, D Vuichard, AF Widmer, G Zanetti, SP Kuster
Swissnoso 20 (1), 1-8, 2015
13*2015
Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis
D Vuichard, M Weisser, C Orasch, R Frei, D Heim, JR Passweg, ...
BMC infectious diseases 14 (1), 573, 2014
132014
The system can't perform the operation now. Try again later.
Articles 1–20